In the first quarter of 2021, several developments in the reviews of the following clinical indicator (CI) sets were achieved.
Pathology: In March, the Royal College of Pathologists Australasia endorsed the new Version 5 of the Pathology clinical indicators. This will be available for collection in from July to December 2021. The development of Version 5 was led by Dr Daman Langguth (RCPA), with representation from the Australian College of Nursing and the Australian Institute of Medical Scientists.
Emergency Medicine: Also in March, the Emergency Medicine clinical indicators Version 7 was finalised and submitted for endorsement to the Australasian College for Emergency Medicine. The development of Version 7 was led by Dr Sandra Brownlea (ACEM), with representation from the College of Emergency Nursing Australasia.
Rehabilitation Medicine: In April, the Australasian Faculty of Rehabilitation Medicine and the Australasian Rehabilitation Outcomes Centre endorsed the Version 7, Rehabilitation Medicine clinical indicators. This work was led by Ms Frances Simmonds (AROC) with representation from AFRM. The Version 7 User Manual will be available for 1H2021 data by the end of May 2021.
Hospital in the Home: Work is currently ongoing with the development of Version 6 of the Hospital in the Home clinical indicators, following the Working Part Meeting on the 25th of March. The Working Party is being led by Dr James Pollard from the Hospital in the Home Society of Australasia, with representation from the Australian Private Hospital Association.
Medication Safety: Work is currently ongoing with the development of Version 5 of the Medication Safety clinical indicators in light of the recent publication of the polypharmacy QUM indicators and resources, developed by NSW TAG and NSW Health. Dr Shasha Bennett (NSW TAG) is leading this review process, with representation from Queensland Health.
Geriatric Care: Work is currently ongoing with the Australian and New Zealand Society for Geriatric Medicine in developing a brand new set of Geriatric Care clinical Indicators. The work is being led by Dr John Maddison (ANZSGM).
Internal Medicine: Work is currently ongoing with reviewing Area 5: Respiratory disease within the Internal Medicine Version 6.1 set. The work is being led by Dr Henry Marshall, Prof Sheree Smith, and Prof Robert Stirling (TSANZ).
Watch this space for further developments in these and other CI sets the coming months.
The POS team would like to thank the contributions of Dr Brian Collopy, Clinical Advisor, Dr Janney Wale, Consumer Representative, and Mr Stephen Hancock, HSRG Statistician, in all projects mentioned above.
Back to the Newsletter
I agree to the Terms & Conditions
Please Click Here for more information.
For access to Improvement Academy Please Click Here.
Click here to view the current ACHS Newsletter
ACHS member response to survey
ACHS acknowledges the traditional custodians of this land and pays respect to Elders, past and present.